These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 21264466)

  • 1. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
    Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.
    Lai MJ; Soo PC; Lin NT; Hu A; Chen YJ; Chen LK; Chang KC
    Int J Antimicrob Agents; 2013 Aug; 42(2):141-8. PubMed ID: 23742833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant
    Chen X; Liu M; Zhang P; Leung SSY; Xia J
    ACS Infect Dis; 2021 Aug; 7(8):2192-2204. PubMed ID: 34232613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.
    Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC
    Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule.
    Tekbas OF; Ogur R; Korkmaz A; Kilic A; Reiter RJ
    J Pineal Res; 2008 Mar; 44(2):222-6. PubMed ID: 18289175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
    Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
    Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
    Lim JA; Shin H; Heu S; Ryu S
    J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S.
    Lim JA; Shin H; Kang DH; Ryu S
    Res Microbiol; 2012 Apr; 163(3):233-41. PubMed ID: 22289622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
    Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
    Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cajanol inhibits the growth of Escherichia coli and Staphylococcus aureus by acting on membrane and DNA damage.
    Liu XL; Zhang XJ; Fu YJ; Zu YG; Wu N; Liang L; Efferth T
    Planta Med; 2011 Jan; 77(2):158-63. PubMed ID: 20803417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria.
    Kaul M; Zhang Y; Parhi AK; Lavoie EJ; Pilch DS
    Biochem Pharmacol; 2014 Jun; 89(3):321-8. PubMed ID: 24637241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
    Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
    Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.